This company, selling around $11, was mentioned by Individual Investor as a good buy. What do you think. I found the company info in one of the Web sites.
Matritech, Inc., based in Cambridge, MA, is using its proprietary NUCLEAR MATRIX PROTEIN (NMP) technology, discovered at the Massachusetts Institute of Technology (MIT) and Johns Hopkins University School of Medicine and licensed exclusively to Matritech, to develop and commercialize innovative serum-, cell-, and urine-based NMP diagnostics that enable physicians to reliably detect and monitor the presence of bladder, breast, colorectal, cervical and prostate cancers. The company recently received notification from the FDA that its NMP22 Test Kit for bladder cancer is approvable.
Kris |
